Growth hormone secretagogue receptor dimers: A new pharmacological target

eNeuro

Volumn 2, Issue 2, 2015, Pages

  Wellman, Martin ^a   Abizaid, Alfonso ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

G protein coupled receptor; Ghrelin; Growth hormone secretagogue receptor; Pharmacology; Receptor dimerization

Indexed keywords

EID: 85016630584     PISSN: None     EISSN: 23732822     Source Type: Journal    
DOI: 10.1523/ENEURO.0053-14.2015     Document Type: Review

References (132)

1. Abizaid A (2009) Ghrelin and dopamine: new insights on the peripheral regulation of appetite. J Neuroendocrinol 21:787-793. Cross-Ref Medline
2. Abizaid A, Horvath TL (2008) Brain circuits regulating energy homeostasis. Regul Pept 149:3-10. CrossRef Medline
3. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschöp MH, Gao XB, Horvath TL (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116:3229-3239. CrossRef
4. Abizaid A, Mineur YS, Roth RH, Elsworth JD, Sleeman MW, Picciotto MR, Horvath TL (2011) Reduced locomotor responses to cocaine in ghrelin-deficient mice. Neuroscience 192:500-506. CrossRef Medline
5. Abramowski D, Rigo M, Duc D, Hoyer D, Staufenbiel M (1995) Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34:1635-1645. Medline
6. Alex KD, Pehek EA (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320. CrossRef Medline
7. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, DiMarchi R, Tschöp M, Roth RH, Gao XB, Horvath TL (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 29:14057-14065. CrossRef Medline
8. Archer ZA, Dieguez C, Mitchell SE, Nogueiras R, Rayner DV, Tovar S, Williams LM (2004) Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53:2552-2558. CrossRef
9. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52:947-952. Medline
10. Banks WA, Tschöp M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827. CrossRef Medline
11. Blum ID, Patterson Z, Khazall R, Lamont EW, Sleeman MW, Horvath TL, Abizaid A (2009) Reduced anticipatory locomotor responses to scheduled meals in ghrelin receptor deficient mice. Neuroscience 164:351-359. CrossRef Medline
12. Breit A, Wolff K, Kalwa H, Jarry H, Büch T, Gudermann T (2006) The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors. J Biol Chem 281:37447-37456. CrossRef Medline
13. Brown SA, Vik PW, Patterson TL, Grant I, Schuckit MA (1995) Stress, vulnerability and adult alcohol relapse. J Stud Alcohol 56:538-545. Medline
14. Brunetti L, Recinella L, Orlando G, Michelotto B, Di Nisio C, Vacca M (2002) Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 454: 189-192. Medline
15. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, Dekoning J, Baetscher M, Cone RD (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141:3518-3521. CrossRef Medline
16. Cabral A, Fernandez G, Perello M (2013) Analysis of brain nuclei accessible to ghrelin present in the cerebrospinal fluid. Neuroscience 253:406-415. CrossRef Medline
17. Camiña JP, Lodeiro M, Ischenko O, Martini AC, Casanueva FF (2007) Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and β-arrestins. J Cell Physiol 213:187-200. CrossRef Medline
18. Carroll ME (1985) The role of food deprivation in the maintenance and reinstatement of cocaine-seeking behavior in rats. Drug Alcohol Depend 16:95-109. Medline
19. Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P (2001) Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 13:1071-1077. Medline
20. Centonze D, Grande C, Saulle E, Martín AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, Calabresi P (2003) Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci 23:8506-8512. Medline
21. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97-102. CrossRef Medline
22. Chen YW, Morganstern I, Barson JR, Hoebel BG, Leibowitz SF (2014) Differential role of D1 and D2 receptors in the perifornical lateral hypothalamus in controlling ethanol drinking and food intake: possible interaction with local orexin neurons. Alcohol Clin Exp Res 38:777-786. CrossRef
23. Chuang JC, Perello M, Sakata I, Osborne-Lawrence S, Savitt JM, Lutter M, Zigman JM (2011) Ghrelin mediates stress-induced food-reward behavior in mice. J Clin Invest 121:2684-2692. CrossRef Medline
24. Clifford PS, Rodriguez J, Schul D, Hughes S, Kniffin T, Hart N, Eitan S, Brunel L, Fehrentz JA, Martinez J, Wellman PJ (2012) Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors. Addict Biol 17:956-963. CrossRef Medline
25. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD (1999) Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24:155-163. Medline
26. Cowley MA, Smith RG, Diano S, Tschöp M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, Garcia-Segura LM, Nillni EA, Mendez P, Low MJ, Sotonyi P, Friedman JM, Liu H, Pinto S, Colmers WF, Cone RD, Horvath TL (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37:649-661. Medline
27. Currie PJ, John CS, Nicholson ML, Chapman CD, Loera KE (2010) Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization. Pharmacol Biochem Behav 97:152-155. CrossRef
28. Cvejic S, Devi LA (1997) Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J Biol Chem 272: 26959-26964. Medline
29. Damian M, Marie J, Leyris JP, Fehrentz JA, Verdie P, Martinez J, Baneres JL, Mary S (2011) High constitutive activity is an intrinsic feature of the ghrelin receptor protein. J Biol Chem 287:3630-3641.
30. Davis JF, Choi DL, Clegg DJ, Benoit SC (2011) Signaling through the ghrelin receptor modulates hippocampal function and meal anticipation in mice. Physiol Behav 103:39-43. CrossRef Medline
31. Després JP, Golay A, Sjöström L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353:2121-2134. CrossRef Medline
32. Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA, Jerlhag E (2011) The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol 340:80-87. CrossRef Medline
33. Di Giovanni G, Di Matteo V, Di Mascio M, Esposito E (2000) Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35:53-61. CrossRef
34. Double KL, Crocker AD (1995) Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone. Proc Natl Acad SciUSA92:1669-1673. Medline
35. Egecioglu E, Jerlhag E, Salomé N, Skibicka KP, Haage D, Bohlooly-Y M, Andersson D, Bjursell M, Perrissoud D, Engel JA, Dickson SL (2010) Ghrelin increases intake of rewarding food in rodents. Addict Biol 15:304-311. CrossRef Medline
36. Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Özlen N (2008) Effects of second generation antipsychotics on leptin and ghrelin. Prog Neuropsychopharmacol Biol Psychiatry 32:1434-1438. CrossRef Medline
37. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168. CrossRef Medline
38. Fredholm BB, Hökfelt T, Milligan G (2007) G-protein-coupled receptors: an update. Acta Physiol 190:3-7. CrossRef Medline
39. Garfield AS, Heisler LK (2009) Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol 587: 49-60. CrossRef Medline
40. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988. CrossRef Medline
41. Goeders NE (2003) The impact of stress on addiction. Eur Neuropsychopharmacol 13:435-441. Medline
42. Granado N, Ortiz O, Suárez LM, Martín ED, Ceña V, Solís JM, Moratalla R (2008) D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-induced arc and zif268 expression in the hippocampus. Cereb Cortex 18:1-12. CrossRef Medline
43. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48:23-29. Medline
44. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA105:6320-6325. CrossRef Medline
45. Hebert TE, Moffett S, Morello J-P, Loisel TP, Bichet DG, Barret C, Bouvier M (1996) A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392. Medline
46. Higgins GA, Fletcher PJ (2003) Serotonin and drug reward: focus on 5-HT2C receptors. Eur J Pharmacol 480:151-162. Medline
47. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW (2003) High constitutive signaling of the ghrelin receptor—identi-fication of a potent inverse agonist. Mol Endocrinol 17:2201-2210. CrossRef Medline
48. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW (2004) Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806-53817. CrossRef Medline
49. Hosoda H, Kojima M, Matsuo H, Kangawa K (2000) Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909-913. CrossRef Medline
50. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, et al. (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977. Medline
51. Ikemoto S (2003) Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J Neurosci 23: 9305-9311. Medline
52. Ikemoto S, Glazier BS, Murphy JM, McBride WJ (1997) Role of Dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17:8580-8587. Medline
53. Inui A (2001) Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2:551-560. CrossRef Medline
54. Jégou S, Boutelet I, Vaudry H (2000) Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus. J Neuroendocrinol 12:501-505. Medline
55. Jerlhag E, Egecioglu E, Dickson S, Engel J (2010) Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology (Berl) 211:415-422. CrossRef Medline
56. Jiang H, Betancourt L, Smith RG (2006) Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 het-erodimers. Mol Endocrinol 20:1772-1785. CrossRef Medline
57. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao W-J, Johnson M, Gunwaldsen C, Huang L-Y, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, Gerald C (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674-679. CrossRef Medline
58. Kammerer RA, Frank S, Schulthess T, Landwehr R, Lustig A, Engel J (1999) Heterodimerization of a functional GABAB receptor is mediated by parallel coiled-coil α-helices. Biochemistry 38:13263-13269. Medline
59. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, Bettler B (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687. CrossRef Medline
60. Kern A, Albarran-Zeckler R, Walsh HE, Smith RG (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73:317-332. CrossRef Medline
61. Kistler H, Lauber, Lichtensteiger (1998) Different developmental patterns of melanocortin MC3 and MC4 receptor mRNA: predominance of Mc4 in fetal rat nervous system. J Neuroendocrinol 10:133-146. Medline
62. Klingenberg M (1981) Membrane protein oligomeric structure and transport function. Nature 290:449-454. Medline
63. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660. CrossRef Medline
64. Kola B, Korbonits M (2009) Shedding light on the intricate puzzle of ghrelin’s effects on appetite regulation. J Endocrinol 202:191-198. CrossRef Medline
65. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-White J, Liposits Z, Kunos G, Grossman AB, Fekete C, Korbonits M (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 3:e1797. CrossRef
66. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits M (2005) Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated Protein kinase. J Biol Chem 280:25196-25201. CrossRef Medline
67. Kumar KG, Sutton GM, Dong JZ, Roubert P, Plas P, Halem HA, Culler MD, Yang H, Dixit VD, Butler AA (2009) Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides 30:1892-1900. CrossRef Medline
68. Kuner R, Köhr G, Grünewald S, Eisenhardt G, Bach A, Kornau HC (1999) Role of heteromer formation in GABAB receptor function. Science 283:74-77. Medline
69. Kurumiya S, Nakajima S (1988) Dopamine D1 receptors in the nucleus accumbens: involvement in the reinforcing effect of tegmental stimulation. Brain Res 448:1-6. Medline
70. Leggio L, Zywiak WH, Fricchione SR, Edwards SM, de la Monte SM, Swift RM, Kenna GA (2014) Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation. Biol Psychiatry 76:734-741. CrossRef Medline
71. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L, Chen L, Chen TM, Chin MC, Chong J, Crook BE, Czaplinska A, Dang CN, Datta S, Dee NR, et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-176. CrossRef Medline
72. Lim CT, Kola B, Feltrin D, Perez-Tilve D, Tschöp MH, Grossman AB, Korbonits M (2013) Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism. Mol Cell Endocrinol 365:303-308. CrossRef Medline
73. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, Birnbaum S, Yanagisawa M, Elmquist JK, Nestler EJ, Zigman JM (2008) The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11:752-753. CrossRef Medline
74. Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106. Medline
75. Martin JR, Bös M, Jenck F, Moreau J-L, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HHG, Broekkamp CLE, Ruigt GSF, Köhler C, van Delft AM (1998) 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913-924. Medline
76. Matthies H, Becker A, Krug M (1997) Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. Neuroreport 8:3533. Medline
77. Meador-Woodruff JH, Mansour A, Bunzow JR, Van Tol HH, Watson SJ, Civelli O (1989) Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA86:7625-7628. Medline
78. Mercuri NB, Bernardi G (2005) The magic of l-dopa: why is it the gold standard Parkinson’s disease therapy? Trends Pharmacol Sci 26: 341-344. CrossRef Medline
79. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225.
80. Mitchell V, Bouret S, Beauvillain J-C, Schilling A, Perret M, Kordon C, Epelbaum J (2001) Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microce-bus murinus (Primate, Lemurian) and rat forebrain and pituitary. J Comp Neurol 429:469-489. Medline
81. Moon M, Kim H, Hwang L, Seo J-H, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh M, Lee KT, Park S (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation. Neurotox Res 15:332-347. CrossRef Medline
82. Nakajima S (1989) Subtypes of dopamine receptors involved in the mechanism of reinforcement. Neurosci Biobehav Rev 13:123-128. Medline
83. Nakajima S, McKenzie GM (1986) Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390. Pharmacol Biochem Behav 24:919-923. Medline
84. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165-205. Medline
85. Nonogaki K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152-1156. CrossRef Medline
86. Nonogaki K, Ohashi-Nozue K, Oka Y (2006) A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochem Biophys Res Commun 341:703-707. CrossRef Medline
87. Otmakhova NA, Lisman JE (1996) D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses. J Neurosci 16:7478-7486. Medline
88. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S (2006) Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116:760-768. CrossRef
89. Park PS, Filipek S, Wells JW, Palczewski K (2004) Oligomerization of G protein-coupled receptors: past, present, and future. Biochemistry 43:15643-15656. CrossRef Medline
90. Patterson ZR, Ducharme R, Anisman H, Abizaid A (2010) Altered metabolic and neurochemical responses to chronic unpredictable stressors in ghrelin receptor-deficient mice. Eur J Neurosci 32: 632-639. CrossRef Medline
91. Perello M, Sakata I, Birnbaum S, Chuang JC, Osborne-Lawrence S, Rovinsky SA, Woloszyn J, Yanagisawa M, Lutter M, Zigman JM (2010) Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry 67:880-886. CrossRef Medline
92. Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, Parmentier M, Spedding M (2007) International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 59:5-13. CrossRef Medline
93. Poncelet M, Maruani J, Calassi R, Soubrié P (2003) Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 343:216-218. Medline
94. Rediger A, Tarnow P, Bickenbach A, Schaefer M, Krude H, Grüters A, Biebermann H (2009) Heterodimerization of hypothalamic G-protein-coupled receptors involved in weight regulation. Obes Facts 2:80-86. CrossRef Medline
95. Rediger A, Piechowski CL, Yi C-X, Tarnow P, Strotmann R, Grüters A, Krude H, Schöneberg T, Tschöp MH, Kleinau G, Biebermann H (2011) Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. J Biol Chem 286:39623-39631. CrossRef Medline
96. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244. Medline
97. Robbins MJ, Calver AR, Filippov AK, Hirst WD, Russell RB, Wood MD, Nasir S, Couve A, Brown DA, Moss SJ, Pangalos MN (2001) GABA(B)2 is essential for g-protein coupling of the GABA(B) receptor heterodimer. J Neurosci 21:8043-8052. Medline
98. Romano C, Yang W-L, O’Malley KL (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271:28612-28616. Medline
99. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD (1993) Identification of a receptor for gamma melanotropin and other proopiomelano-cortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA90:8856-8860. Medline
100. Rosenzweig-Lipson S, Comery T, Marquis K, Gross J, Dunlop J (2012) 5-HT2C agonists as therapeutics for the treatment of schizophrenia. In: Novel antischizophrenia treatments (Geyer MA, Gross G, eds), pp 147-165. Berlin: Springer.
101. Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ (1997) 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology (Berl) 133:309-312. Medline
102. Sawaguchi T, Goldman-Rakic PS (1994) The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71:515-28.
103. Sawaguchi T, Matsumura M, Kubota K (1990) Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 63:1401-1412.
104. Schellekens H, van Oeffelen WE, Dinan TG, Cryan JF (2013) Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem 288:181-191. CrossRef Medline
105. Schellekens H, De Francesco PN, Kandil D, Theeuwes WF, McCarthy T, van Oeffelen WEPA, Perelló M, Giblin L, Dinan TG, Cryan JF (2015) Ghrelin’s orexigenic effect is modulated via a serotonin 2C receptor interaction. ACS Chem Neurosci. Advance online publication.
106. Seamans JK, Floresco SB, Phillips AG (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18:1613-1621. Medline
107. Shalev U, Yap J, Shaham Y (2001) Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J Neurosci 21: RC129. Medline
108. Shalev U, Highfield D, Yap J, Shaham Y (2000) Stress and relapse to drug seeking in rats: studies on the generality of the effect. Psychopharmacology (Berl) 150:337-346. Medline
109. Shaw AM, Irani BG, Moore MC, Haskell-Luevano C, Millard WJ (2005) Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice. Peptides 26:1720-1727. CrossRef Medline
110. Sinha R, Garcia M, Paliwal P, Kreek M, Rounsaville BJ (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324-331. CrossRef Medline
111. Somerville EM, Horwood JM, Lee MD, Kennett GA, Clifton PG (2007) 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. Eur J Neurosci 25:3115-3124. CrossRef Medline
112. Suchankova P, Steensland P, Fredriksson I, Engel JA, Jerlhag E (2013) Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS One 8:e71284. CrossRef Medline
113. Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, Babin MJ, Meyer EA, Butler AA (2006) Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147:2183-2196. CrossRef Medline
114. Szidonya L, Cserzö M, Hunyady L (2008) Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J Endocrinol 196:435-453. CrossRef Medline
115. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD (1998) Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139:4420-4423. CrossRef Medline
116. Tao YX, Huang H, Wang ZQ, Yang F, Williams JN, Nikiforovich GV (2010) Constitutive activity of neural melanocortin receptors. In: Methods in enzymology (Conn PM, ed), pp 267-279. New York: Academic.
117. Thiele TE, Van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ (1998) Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol 274:R248-R254.
118. Vucetic Z, Reyes TM (2010) Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip Rev Syst Biol Med 2:577-593. CrossRef Medline
119. Wellman PJ, Clifford PS, Rodriguez JA (2013) Ghrelin and ghrelin receptor modulation of psychostimulant action. Front Neurosci 7:171. CrossRef
120. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679-682. CrossRef Medline
121. White NM (1988) Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine. Life Sci 43:7-12. Medline
122. White NM (1989) Reward or reinforcement: what’s the difference? Neurosci Biobehav Rev 13:181-186. Medline
123. Willesen MG, Kristensen P, Rømer J (1999) Co-localization of growth hormone secretagogue receptor and npy mrna in the arcuate nucleus of the rat. Neuroendocrinology 70:306-316. Medline
124. Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral δ9-THC. Physiol Behav 65:343-346. Medline
125. Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572-575. CrossRef Medline
126. Wise R (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14:169-183. CrossRef Medline
127. Wise RA (2006) Role of brain dopamine in food reward and reinforcement. Philos Trans R Soc B Biol Sci 361:1149-1158. CrossRef Medline
128. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132:387-396. Cross-Ref Medline
129. Young SL, Taylor M, Lawrie SM (2015) “First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol (Oxf) 29:353-362. CrossRef Medline
130. Zheng J, Dobner A, Babygirija R, Ludwig K, Takahashi T (2009) Effects of repeated restraint stress on gastric motility in rats. Am J Physiol 296:R1358-R1365. CrossRef Medline
131. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115:3564-3572. CrossRef Medline
132. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006) Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494:528-548. CrossRef Medline